12:00 AM
Oct 22, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Lexicon completes follow-on

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), The Woodlands, Texas
Business: Gastrointestinal, Autoimmune, Functional genomics

Read the full 42 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >